Otsuka Technical Visit
HMC's Purell PP grades for the medical market are made under specific manufacturing procedures and offer consistency of formulation, continuity of supply, and are certified according to regulatory standards such as US Pharmacopeia, European Pharmacopeia and Drug Master File listing supporting the use of the resins in medical and pharmaceutical applications.
On 20-21 January, 2020 HMC received a technical auditing team visit from key customer, Otsuka Group the world-class pharmaceutical and nutraceutical products manufacturer. Otsuka has been manufacturing using the HMC medical PP grade, Purell RP271G since 2012.
Attending the HMC plant locations for the audit review were:
- Daishu Nambu, Sr. Manager, Otsuka Pharmaceutical Factory, Inc. Japan - Quality Management
- Xiaming Han, Supervisor, Otsuka Pharmaceutical Factory, Inc. Japan - Overseas Technical Office
- Muhammad Nur Husaini, Director, PT. Otsuka Indonesia, Indonesia - QMS Sub-Division
- Siti Rochimah, Manager, PT. Otsuka Indonesia, Indonesia - Manufacturing Process Development
- Hendri Yanto Prabowo, Head of QC, PT WIDATRA BHAKTI, Indonesia - QC
- Dian Anggraeny, Head of TD, PT WIDATRA BHAKTI, Indonesia - Technical Department
- Mohab Eldesouki, QA Manager, Egypt Otsuka Pharmaceutical Co., S.A.E - Egypt QA
The Otsuka technical group was hosted by HMC executives:
- Chookiat Kosintrakarn, VP Sales and Innovation
- Chatri Phlappla, VP Operation and Manufacturing
- Kessaraporn Trongtorsak, Department Manager, PP Solutions
- Oraphin Teeranaamornwong, Department Manager, Technology
As part of Otsuka's regional trip auditing suppliers, the HMC Purell audit covered all functions from production to supporting functions. The group also had a chance to make a plant tour at Map-Ta-Phut focused on the CCR control room, laboratory, warehouses and bagging areas.